How to buy EBOS Group shares
Own EBOS Group shares in just a few minutes.
EBOS Group Limited is a medical distribution business based in Australia. EBOS Group shares (EBO) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. EBOS Group has a trailing 12-month revenue of around $8.8 billion.
How to buy shares in EBOS Group
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for EBOS Group . Find the share by name or ticker symbol: EBO. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until EBOS Group reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $N/A, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of EBOS Group . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
EBOS Group share priceUse our graph to track the performance of EBO stocks over time.
EBOS Group shares at a glance
|52-week range||AUDA$18.8 - AUDA$24.25|
|50-day moving average||AUDA$21.28|
|200-day moving average||AUDA$21.0652|
|Dividend yield||AUDA$0.65 (2.95%)|
|Earnings per share (TTM)||AUDA$1.006|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy EBOS Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is EBOS Group under- or over-valued?
Valuing EBOS Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of EBOS Group 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
EBOS Group 's P/E ratio
EBOS Group 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, EBOS Group shares trade at around 23x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
EBOS Group 's PEG ratio
EBOS Group 's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.3724. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into EBOS Group 's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
EBOS Group 's EBITDA
EBOS Group 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $295.9 million.
The EBITDA is a measure of a EBOS Group 's overall financial performance and is widely used to measure a its profitability.
EBOS Group financials
|Revenue TTM||$8.8 billion|
|Operating margin TTM||2.97%|
|Gross profit TTM||$917.8 million|
|Return on assets TTM||4.68%|
|Return on equity TTM||12.67%|
|Market capitalisation||$3.5 billion|
TTM: trailing 12 months
EBOS Group share dividends
Dividend payout ratio: 65.45% of net profits
Recently EBOS Group has paid out, on average, around 65.45% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.95% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), EBOS Group shareholders could enjoy a 2.95% return on their shares, in the form of dividend payments. In EBOS Group 's case, that would currently equate to about A$0.65 per share.
EBOS Group 's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 23 September 2020 (the "ex-dividend date").
EBOS Group share price volatility
Over the last 12 months, EBOS Group 's shares have ranged in value from as little as $18.8 up to $24.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while EBOS Group 's is 0.3584. This would suggest that EBOS Group 's shares are less volatile than average (for this exchange).
EBOS Group overview
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand. It operates in two segments, Healthcare and Animal Care. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services. It also offers vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; community based health care services and programs; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that allows members drive their retail businesses. In addition, the company supplies health and wellness products public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers contract logistics services, such as healthcare distribution, warehousing, clinical trial management, and product registration services; and clinical trial logistics. Additionally, the company provides pet nutrition products, treats, clean-up products, grooming, and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was founded in 1922 and is headquartered in Docklands, Australia.
Frequently asked questions
Ask an Expert